Article Details

The Goldman Sachs Group has reduced its rating on MorphoSys (NASDAQ:MOR).

Retrieved on: 2022-12-17 18:52:45

Tags for this article:

Click the tags to see associated articles and topics

The Goldman Sachs Group has reduced its rating on MorphoSys (NASDAQ:MOR).. View article details on hiswai:

Excerpt

The report was about the company's investment strategy. ... JMP Securities gave the stock the rating of “market outperform” and lowered their ...

Article found on: beststocks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up